MS relapses rates were also low and consistent with prior results.19 One patient with severe MS at baseline aspirated and had respiratory failure after discontinuing anti–PD-1 treatment; this was thought to be at least partially related to an MS pseudo-exacerbation. Here, PDCD1 is linked to myeloid sarcoma.